Skip to content
Thursday, November 12, 2026
OddScore UK provides expert football analysis, betting insi…

Providing Stem Cells in Utero to Infants with Neural Tube Defect Boosts Quality of Life, Research Shows

A pioneering research effort has discovered that delivering regenerative cells to developing infants affected by spina bifida as part of a surgical repair can be a "major milestone" in managing prenatal disorders.

Trial Details and Safety

The US-based trial examined six fetuses with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells on the exposed area of the baby's spinal cord while the defect was being closed.

Importantly, the regenerative treatment proved to be secure. The study team reported that the treatment did not lead to cancerous growths, hinder surgical recovery, or block the correction of associated brain abnormalities.

Positive Developments

Imaging conducted after delivery confirmed a successful correction of hindbrain herniation in each of the babies. This neurological improvement is a key indicator for better mobility and function.

"Should it enable more children capable of walking who otherwise would not, then it would become their standard of care," noted the study director. "The results are extremely promising and pave the way for a variety of prospective innovative interventions."

Broader Impact and Encouragement

Independent medical specialists proposed that additional validation of these noted improvements could announce a "fresh chapter" in in-utero treatment. The potential to improve nerve function impairment seen in utero is considered a transformative goal.

Particularly welcome would be improvements in continence and digestive health, which are frequent complications for individuals living with this condition.

The Path Forward

Despite this being a first-in-human effort involved a limited number of patients, its established security and encouraging indicators offer a robust platform for broader investigative efforts. The integration of stem cell therapy with current in-utero repair procedures presents significant potential for transforming outcomes for infants diagnosed prenatally with spina bifida.

MH
About the author

Michael Harris

A data-driven football analyst with a background in sports statistics, specializing in European leagues and predictive modeling.

OddScore UK

Type to search articles.